This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Choroidal Neovascularization  • Retinal/ Chorioretinal Disorders  • Prognosis/ Outcomes  • Alert me on articles by topic  Social Bookmarking   What's this?

Arch Ophthalmol. 2004;122:1705-1706.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In this month’s issue, the Subretinal Surgery Trial (SST) investigators report the outcomes of surgical removal of subfoveal choroidal neovascularization (CNV) compared with a control group of patients with the ocular histoplasmosis syndrome (OHS) and with idiopathic CNV.^1-2 The goal of the SST was to answer the question of whether surgery offered a benefit over the often unfavorable natural history of the disease. Previously published studies showed promise for a surgical approach,^3-5 but these studies had no concurrent controls without surgery to determine if the outcomes were better than the natural history and had limited follow-up to determine if such outcomes were sustained.

Sponsored by the National Eye Institute, the SST was a randomized prospective clinical trial conducted by retina-trained physician investigators, supporting ancillary personnel (coordinators, vision examiners, and photographers) at various medical centers, a coordinating center, and photograph reading center. The SST protocol contained strict eligibility criteria, photographic documentation . . . [Full Text of this Article]

AUTHOR INFORMATION
Harry W. Flynn, Jr, MD; Ingrid U. Scott, MD, MPH

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Surgical Removal vs Observation for Subfoveal Choroidal Neovascularization, Either Associated With the Ocular Histoplasmosis Syndrome or Idiopathic: I. Ophthalmic Findings From a Randomized Clinical Trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9
Submacular Surgery Trials Research Group
Arch Ophthalmol. 2004;122(11):1597-1611.
ABSTRACT | FULL TEXT  

Surgical Removal vs Observation for Subfoveal Choroidal Neovascularization, Either Associated With the Ocular Histoplasmosis Syndrome or Idiopathic: II. Quality-of-Life Findings From a Randomized Clinical Trial: SST Group H Trial: SST Report No. 10
Submacular Surgery Trials Research Group
Arch Ophthalmol. 2004;122(11):1616-1628.
ABSTRACT | FULL TEXT